Compare ADNT & ECAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADNT | ECAT |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2016 | 2021 |
| Metric | ADNT | ECAT |
|---|---|---|
| Price | $21.62 | $15.38 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.41 | N/A |
| AVG Volume (30 Days) | ★ 839.6K | 495.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $17,439,000,000.00 | N/A |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | $349.50 | ★ $6.32 |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $14.87 | $13.36 |
| 52 Week High | $27.32 | $17.14 |
| Indicator | ADNT | ECAT |
|---|---|---|
| Relative Strength Index (RSI) | 51.72 | 62.42 |
| Support Level | $18.69 | $15.32 |
| Resistance Level | $22.35 | $15.69 |
| Average True Range (ATR) | 1.02 | 0.18 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 58.17 | 59.26 |
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
BlackRock ESG Capital Allocation Trust is a non-diversified, closed-ended management investment company. The Trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation.